Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT06367829
Other study ID # WO.24.025
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date January 8, 2024
Est. completion date January 8, 2025

Study information

Verified date April 2024
Source JointResearch
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The research questions this study aims to answer are as follows: Primary research question: "Do primary total hip arthroplasties for patients with OA, hip fracture or osteonecrosis with the 150mm Lubinus SPII hip stem have better mortality and stem revision rates than primary total hip arthroplasties with the 130mm hip stem?" Secondary aims include: - How does line-to-line cementation, compare to undersized cementation in primary total hip arthroplasty for patients with OA, hip fracture, or osteonecrosis when comparing equal size Lubinus SPII hip stems implanted with different cementation techniques? - Does the Lubinus SPII 150mm hip stem perform equal to the Lubinus SPII 130mm hip stem in primary total hip arthroplasties for patients with OA, hip fracture or osteonecrosis when comparing patient reported outcome measures? To answer these questions, this study has been allowed use of registered data from the LROI (dutch arthroplasty registry) and the SAR (swedish arthroplasty registry). After exclusion of patients who did not meet inclusion criteria between 2007-2020, approximately 110000 patients remain eligible for analysis.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 110000
Est. completion date January 8, 2025
Est. primary completion date July 14, 2024
Accepts healthy volunteers No
Gender All
Age group 5 Years to 105 Years
Eligibility Inclusion Criteria: - Listed in registry for primary hip arthroplasty. - Listed in registry with an indication of osteoarthritis, osteonecrosis or hip fracture. - Received the Lubinus SPII hip stem, 130mm or 150mm, for their primary hip arthro- plasty. - End point listed in registry (Alive, Deceased or revision). Exclusion Criteria: - Patients who received the Lubinus SPII 150 XL conus stem.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Lubinus SPII hip stem 130mm
Shorter length of the SPII hip stem
Lubinus SPII hip stem 150mm
Longer length of the SPII hip stem

Locations

Country Name City State
Netherlands OLVG Amsterdam Noord Holland

Sponsors (5)

Lead Sponsor Collaborator
JointResearch Göteborg University, Leiden University Medical Center, OLVG, Uppsala University

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mortality rate Time from primary hip surgery to patient death, per hip stem length From date of surgery to date of event (death), minimally 2 years up to 16 years (2007-2023)
Primary Revision rate Time from primary hip surgery to implant failure, per hip stem length From date of surgery to date of event (revision), minimally 2 years up to 16 years (2007-2023)
Secondary NRS pain score pain score for rest and activity, rated 0 - 10 (10 is max pain) before surgery, 3-6 months after surgery, 12 months after surgery
Secondary Oxford hip score Hip functionality and pain intensity score , 0 - 60, 60 is max pain/least functionality before surgery, 3-6 months after surgery, 12 months after surgery
Secondary EQ - 5D Quality of life measurement based on 5 questions with a score of 0 - 100 (how well does patient experience health, 100 is best) before surgery, 3-6 months after surgery, 12 months after surgery
Secondary HOOS - PS Hip functionality, disability and pain test, 5 point liker scale ( 0 - 4), higher score is more functional difficulty before surgery, 3-6 months after surgery, 12 months after surgery
Secondary Revision rate Time from primary hip surgery to implant failure, per cementation type From date of surgery to date of event (death), minimally 2 years up to 16 years (2007-2023)
Secondary Mortality rate Time from primary hip surgery to patient death, per cementation type From date of surgery to date of event (revision), minimally 2 years up to 16 years (2007-2023)
See also
  Status Clinical Trial Phase
Recruiting NCT02993029 - 99Tc-MDP Treatment for Knee Osteoarthritis N/A
Enrolling by invitation NCT05411393 - Synergizing Home Health Rehabilitation Therapy N/A
Recruiting NCT05621356 - Monitoring Allergen Immunotherapy in Allergic Rhinitis
Not yet recruiting NCT05593380 - The Effect of BIA Monitoring of Brain Edema on the Neurological Prognosis of Supratentorial Massive ICH N/A
Recruiting NCT05964725 - The Study on Effect and Neural Network Mechanism of Transcranial Direct Current Stimulation for Sudden Deafness With Tinnitus N/A
Not yet recruiting NCT05417711 - Efficacy of Transcutaneous Vagus Nerve Stimulation Paired With Tailor-Made Notched Music Therapy Versus Tailor-made Notched Music Training for Chronic Subjective Tinnitus N/A
Recruiting NCT04013646 - Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients Phase 1/Phase 2
Not yet recruiting NCT03477240 - Feasibility Study Of A Telephonic Questionnaire For Follow-Up Of Locally Advanced Cervical Cancer Patients
Recruiting NCT06035783 - Calcium Reduction by Orbital Atherectomy in Western Europe
Recruiting NCT05413707 - Weber B Ankle Fractures With Associated Posterior Malleolus Fracture N/A
Completed NCT01364649 - Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction Phase 3
Completed NCT04682951 - Good Prognosis Factors After Decompressive Craniectomy : a Ten-year Retrospective Study
Recruiting NCT05616559 - Precision Medicine in the Depression Treatment
Recruiting NCT06441110 - Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer Phase 3
Recruiting NCT03223142 - Standardization of Multi-modal Tumor Ablation Therapy System N/A
Completed NCT05594160 - Agentic Self-view as Common Factor in Psychotherapy - Self-efficacy in the Treatment of Inpatients Over the Course of Time
Recruiting NCT05851989 - Study on Prognosis of Acutely Ruptured Intracranial Aneurysms
Not yet recruiting NCT05885919 - Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke Phase 3
Active, not recruiting NCT01235104 - Impact of Total Nephrectomy on Patients With Kidney Stone N/A
Completed NCT01183936 - Trial of Surgical Excision Margins in Thick Primary Melanoma N/A